健康之路(02587)每股定价7.8港元 香港公开发售获34.42倍认购

智通财经
27 Dec 2024

智通财经APP讯,健康之路(02587)公布配发结果,公司全球发售2500万股H股股份,香港公开发售占13.2%,国际配售占86.8%。最终发售价为每股7.8港元,全球发售净筹约1.09亿港元。每手500股,预期H股将于2024年12月30日(星期一)上午九时正开始在联交所买卖。

其中,香港公开发售获34.42倍认购,国际配售获0.98倍认购。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10